Newsletter | August 1, 2025

08.01.25 -- Redefining CGT With Exosomes And EVs

FOCUS ON CLINICAL TRIALS

Redefining CGT With Exosomes And EVs

Cell & Gene Chief Editor Erin Harris shared a timely discussion on the latest advancements and opportunities in the rapidly evolving field of exosomes and extracellular vesicles (EVs) within cell and gene therapy.

Navigating The Future Of Hepatology Clinical Trials

This conversation explores the current and future state of hepatology clinical trials, offering timely perspectives for those looking to navigate this evolving clinical trial landscape.

Is Your Clinical Research Site GCP-Ready?

By fostering a culture of continuous improvement through internal audits, clinical research sites can identify non-compliance issues and enhance their research practices.

Timely Lab Data To Inform Outreach To Healthcare Professionals

Discover how to integrate HIPAA-compliant, deidentified data into commercialization workflows with flexible delivery formats and seamless system integration.

Smartphone-Based Biomarker For Estimating Depression Severity

The study investigates the potential of using smartphones and wearables to create objective biomarkers for mood disorders, specifically focusing on unipolar depression.

CLINICAL TRIALS SOLUTIONS

Your Global CRO Partner In Ophthalmology - TFS HealthScience

Leveraging Mobile Vision Clinics For Clinical Trial Exams - 20/20 Onsite

Bridging The Gap Between CGT Innovation And Reality - InspiroGene

FOCUS ON SUPPLY CHAIN

Pharma Enterprise Resource Planning: From Automation To AI-Driven Insights

Pharmaceutical firms are increasingly turning to enterprise resource planning (ERP) systems to modernize operations. These platforms unify core functions, including supply chain management, manufacturing, and financial planning and analysis.

Ask The Expert: Single-Use Technology In Cell And Gene Therapies

As CGT developers gain knowledge about their processes, single-use technologies (SUT) manufacturers can better address the sector's unique autologous needs by adapting to smaller volume production.

SUPPLY CHAIN SOLUTIONS

Secondary Packaging For Every Single-Use Bag - Single Use Support

EVENTS

Advancing the Future of Cell & Gene Therapy

This 11-12 November, Cell 2025 unites 1,000+ leading experts across the CGT value chain to solve key challenges, from scalable bioprocessing and regulatory hurdles to accelerating development timelines.

 

Gain practical strategies across cell culture, therapy development, and CGT manufacturing, and hear from world-renowned leaders Bobby Gaspar (CEO, Orchard Therapeutics), Christof Von Kalle, (Director & BIH Chair, Research Clinic Luxemburg), and Dame Molly Stevens (University of Oxford). Register Now

Connect With Cell & Gene: